{
    "abstract": "Rabies causes more than 60,000 human deaths annually in areas where the virus is endemic. Importantly, rabies is one of the few pathogens for which there is no treatment following the onset of clinical disease with the outcome of infection being death in almost 100% of cases. Whilst vaccination, and the combination of vaccine and rabies immunoglobulin treatment for post-exposure administration are available, no tools have been identified that can reduce or prevent rabies virus replication once clinical disease has initiated. The search for effective antiviral molecules to treat those that have already developed clinical disease associated with rabies virus infection is considered one of the most important goals in rabies research. The current study assesses a single chain antibody molecule (ScFv) based on a monoclonal antibody that potently neutralises rabies in vitro as a potential therapeutic candidate. The recombinant ScFv was generated in Nicotiana benthamiana by transient expression, and was chemically conjugated (ScFv/RVG) to a 29 amino acid peptide, specific for nicotinic acetylcholine receptor (nAchR) binding in the CNS. This conjugated molecule was able to bind nAchR in vitro and enter neuronal cells more efficiently than ScFv. The ability of the ScFv/RVG to neutralise virus in vivo was assessed using a staggered administration where the molecule was inoculated either four hours before, two days after or four days after infection. The ScFv/RVG conjugate was evaluated in direct comparison with HRIG and a potential antiviral molecule, Favipiravir (also known as T-705) to indicate whether there was greater bioavailability of the ScFv in the brains of treated mice. The study indicated that the approach taken with the ScFv/RVG conjugate may have utility in the design and implementation of novel tools targetting rabies virus infection in the brain.",
    "bib_entries": {
        "b0005": null,
        "b0010": {
            "authors": [
                {
                    "first": "Matthias J.",
                    "initial": "M.J.",
                    "last": "Schnell"
                },
                {
                    "first": "James P.",
                    "initial": "J.P.",
                    "last": "McGettigan"
                },
                {
                    "first": "Christoph",
                    "initial": "C.",
                    "last": "Wirblich"
                },
                {
                    "first": "Amy",
                    "initial": "A.",
                    "last": "Papaneri"
                }
            ],
            "doi": "10.1038/nrmicro2260",
            "firstpage": "51",
            "issn": "17401526",
            "lastpage": "61",
            "pmid": "19946287",
            "pub_year": 2010,
            "title": "The cell biology of rabies virus: Using stealth to reach the brain",
            "volume": "8"
        },
        "b0015": {
            "authors": [
                {
                    "first": "Nicholas",
                    "initial": "N.",
                    "last": "Johnson"
                },
                {
                    "first": "Anthony",
                    "initial": "A.",
                    "last": "Fooks"
                },
                {
                    "first": "Kenneth",
                    "initial": "K.",
                    "last": "McColl"
                }
            ],
            "doi": "10.3201/eid1412.080944",
            "firstpage": "1950",
            "issn": "10806040",
            "lastpage": "1951",
            "pmid": "19046531",
            "pub_year": 2008,
            "title": "Reexamination of human rabies case with long incubation, Australia",
            "volume": "14"
        },
        "b0020": null,
        "b0025": {
            "authors": [
                {
                    "first": "Leonard",
                    "initial": "L.",
                    "last": "Both"
                },
                {
                    "first": "Ashley C.",
                    "initial": "A.C.",
                    "last": "Banyard"
                },
                {
                    "first": "Craig",
                    "initial": "C.",
                    "last": "van Dolleweerd"
                },
                {
                    "first": "Daniel L.",
                    "initial": "D.L.",
                    "last": "Horton"
                },
                {
                    "first": "Julian K.C.",
                    "initial": "J.K.C.",
                    "last": "Ma"
                },
                {
                    "first": "Anthony R.",
                    "initial": "A.R.",
                    "last": "Fooks"
                }
            ],
            "doi": "10.1016/S1473-3099(11)70340-1",
            "firstpage": "397",
            "issn": "14733099",
            "lastpage": "407",
            "pmid": "22541629",
            "pub_year": 2012,
            "title": "Passive immunity in the prevention of rabies",
            "volume": "12"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Prapimporn",
                    "initial": "P.",
                    "last": "Shantavasinkul"
                },
                {
                    "first": "Henry",
                    "initial": "H.",
                    "last": "Wilde"
                }
            ],
            "doi": "10.1016/B978-0-12-387040-7.00013-5",
            "firstpage": "291",
            "issn": "00653527",
            "lastpage": "307",
            "pmid": "21601051",
            "pub_year": 2011,
            "title": "Postexposure Prophylaxis for Rabies in Resource-Limited/Poor Countries",
            "volume": "79"
        },
        "b0035": {
            "authors": [
                {
                    "first": "Mediatrice",
                    "initial": "M.",
                    "last": "Uwanyiligira"
                },
                {
                    "first": "Pierre",
                    "initial": "P.",
                    "last": "Landry"
                },
                {
                    "first": "Blaise",
                    "initial": "B.",
                    "last": "Genton"
                },
                {
                    "first": "Serge",
                    "initial": "S.",
                    "last": "De Valliere"
                }
            ],
            "doi": "10.1093/cid/cis384",
            "firstpage": "201",
            "issn": "10584838",
            "lastpage": "205",
            "pmid": "22550115",
            "pub_year": 2012,
            "title": "Rabies postexposure prophylaxis in routine practice in view of the new centers for disease control and prevention and world health organization recommendations",
            "volume": "55"
        },
        "b0040": {
            "authors": [
                {
                    "first": "Thiravat",
                    "initial": "T.",
                    "last": "Hemachudha"
                },
                {
                    "first": "Jiraporn",
                    "initial": "J.",
                    "last": "Laothamatas"
                },
                {
                    "first": "Charles E.",
                    "initial": "C.E.",
                    "last": "Rupprecht"
                }
            ],
            "doi": "10.1016/S1474-4422(02)00041-8",
            "firstpage": "101",
            "issn": "14744422",
            "lastpage": "109",
            "pmid": "12849514",
            "pub_year": 2002,
            "title": "Human rabies: A disease of complex neuropathogenetic mechanisms and diagnostic challenges",
            "volume": "1"
        },
        "b0045": {
            "authors": [
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Lewis"
                },
                {
                    "first": "Yiguang",
                    "initial": "Y.",
                    "last": "Fu"
                },
                {
                    "first": "Thomas L.",
                    "initial": "T.L.",
                    "last": "Lentz"
                }
            ],
            "doi": "10.1002/(SICI)1097-4598(200005)23:5<720::AID-MUS9>3.0.CO;2-5",
            "firstpage": "720",
            "issn": "0148639X",
            "lastpage": "730",
            "pmid": "10797395",
            "pub_year": 2000,
            "title": "Rabies virus entry at the neuromuscular junction in nerve-muscle cocultures",
            "volume": "23"
        },
        "b0050": {
            "authors": [
                {
                    "first": "M. M.",
                    "initial": "M.M.",
                    "last": "KAPLAN"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "COHEN"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "KOPROWSKI"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "DEAN"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "FERRIGAN"
                }
            ],
            "firstpage": "765",
            "issn": "00429686",
            "lastpage": "775",
            "pmid": "14453773",
            "pub_year": 1962,
            "title": "Studies on the local treatment of wounds for the prevention of rabies.",
            "volume": "26"
        },
        "b0055": {
            "authors": [
                {
                    "first": "C. A.",
                    "initial": "C.A.",
                    "last": "Hanlon"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Niezgoda"
                },
                {
                    "first": "P. A.",
                    "initial": "P.A.",
                    "last": "Morrill"
                },
                {
                    "first": "C. E.",
                    "initial": "C.E.",
                    "last": "Rupprecht"
                }
            ],
            "doi": "10.1016/S0264-410X(00)00516-8",
            "firstpage": "2273",
            "issn": "0264410X",
            "lastpage": "2279",
            "pmid": "11257347",
            "pub_year": 2001,
            "title": "The incurable wound revisited: Progress in human rabies prevention?",
            "volume": "19"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Lin",
                    "initial": "L.",
                    "last": "Fangtao"
                },
                {
                    "first": "Chen",
                    "initial": "C.",
                    "last": "Shubeng"
                },
                {
                    "first": "Wang",
                    "initial": "W.",
                    "last": "Yinzhon"
                },
                {
                    "first": "Sun",
                    "initial": "S.",
                    "last": "Chenzhe"
                },
                {
                    "first": "Zeng",
                    "initial": "Z.",
                    "last": "Fanzhen"
                },
                {
                    "first": "Wang",
                    "initial": "W.",
                    "last": "Guanfu"
                }
            ],
            "doi": "10.1093/clinids/10.Supplement_4.S766",
            "firstpage": "S766",
            "issn": "01620886",
            "lastpage": "S770",
            "pmid": "3206088",
            "pub_year": 1988,
            "title": "Use of serum and vaccine in combination for prophylaxis following exposure to rabies",
            "volume": "10"
        },
        "b0065": {
            "authors": [
                {
                    "first": "William M.",
                    "initial": "W.M.",
                    "last": "Pardridge"
                }
            ],
            "doi": "10.3109/10611860903548354",
            "firstpage": "157",
            "issn": "1061186X",
            "lastpage": "167",
            "pmid": "20064077",
            "pub_year": 2010,
            "title": "Biopharmaceutical drug targeting to the brain",
            "volume": "18"
        },
        "b0070": {
            "authors": [
                {
                    "first": "Monique",
                    "initial": "M.",
                    "last": "Lafon"
                }
            ],
            "doi": "10.1080/13550280590900427",
            "firstpage": "82",
            "issn": "13550284",
            "lastpage": "87",
            "pmid": "15804965",
            "pub_year": 2005,
            "title": "Rabies virus receptors",
            "volume": "11"
        },
        "b0075": {
            "authors": [
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Lafon"
                }
            ],
            "doi": "10.1016/0923-2494(93)80121-E",
            "firstpage": "209",
            "issn": "09232494",
            "lastpage": "222",
            "pmid": "8235045",
            "pub_year": 1993,
            "title": "Rabies virus superantigen",
            "volume": "144"
        },
        "b0080": {
            "authors": [
                {
                    "first": "T. L.",
                    "initial": "T.L.",
                    "last": "Lentz"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Hawrot"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Donnelly-Roberts"
                },
                {
                    "first": "P. T.",
                    "initial": "P.T.",
                    "last": "Wilson"
                }
            ],
            "firstpage": "57",
            "issn": "00652229",
            "lastpage": "71",
            "pmid": "3041753",
            "pub_year": 1988,
            "title": "Synthetic peptides in the study of the interaction of rabies virus and the acetylcholine receptor.",
            "volume": "44"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Thomas L.",
                    "initial": "T.L.",
                    "last": "Lentz"
                },
                {
                    "first": "Thomas G.",
                    "initial": "T.G.",
                    "last": "Burrage"
                },
                {
                    "first": "Abigail L.",
                    "initial": "A.L.",
                    "last": "Smith"
                },
                {
                    "first": "Joan",
                    "initial": "J.",
                    "last": "Crick"
                },
                {
                    "first": "Gregory H.",
                    "initial": "G.H.",
                    "last": "Tignor"
                }
            ],
            "doi": "10.1126/science.7053569",
            "firstpage": "182",
            "issn": "00368075",
            "lastpage": "184",
            "pmid": "7053569",
            "pub_year": 1982,
            "title": "Is the acetylcholine receptor a rabies virus receptor?",
            "volume": "215"
        },
        "b0090": {
            "authors": [
                {
                    "first": "Thomas G.",
                    "initial": "T.G.",
                    "last": "Burrage"
                },
                {
                    "first": "Gregory H.",
                    "initial": "G.H.",
                    "last": "Tignor"
                },
                {
                    "first": "Abigail L.",
                    "initial": "A.L.",
                    "last": "Smith"
                }
            ],
            "doi": "10.1016/0168-1702(85)90014-0",
            "firstpage": "273",
            "issn": "01681702",
            "lastpage": "289",
            "pmid": "3890406",
            "pub_year": 1985,
            "title": "Rabies virus binding at neuromuscular junctions",
            "volume": "2"
        },
        "b0095": {
            "authors": [
                {
                    "first": "Thomas L.",
                    "initial": "T.L.",
                    "last": "Lentz"
                },
                {
                    "first": "Edward",
                    "initial": "E.",
                    "last": "Hawrot"
                },
                {
                    "first": "Paul T.",
                    "initial": "P.T.",
                    "last": "Wilson"
                }
            ],
            "doi": "10.1002/prot.340020406",
            "firstpage": "298",
            "issn": "08873585",
            "lastpage": "307",
            "pmid": "3448605",
            "pub_year": 1987,
            "title": "Synthetic peptides corresponding to sequences of snake venom neurotoxins and rabies virus glycoprotein bind to the nicotinic acetylcholine receptor",
            "volume": "2"
        },
        "b0100": {
            "authors": [
                {
                    "first": "Thomas L.",
                    "initial": "T.L.",
                    "last": "Lentz"
                }
            ],
            "doi": "10.1002/jmr.300030205",
            "firstpage": "82",
            "issn": "09523499",
            "lastpage": "88",
            "pmid": "2361061",
            "pub_year": 1990,
            "title": "Rabies virus binding to an acetylcholine receptor \u03b1\u2010subunit peptide",
            "volume": "3"
        },
        "b0105": {
            "authors": [
                {
                    "first": "Priti",
                    "initial": "P.",
                    "last": "Kumar"
                },
                {
                    "first": "Haoquan",
                    "initial": "H.",
                    "last": "Wu"
                },
                {
                    "first": "Jodi L.",
                    "initial": "J.L.",
                    "last": "McBride"
                },
                {
                    "first": "Kyeong Eun",
                    "initial": "K.E.",
                    "last": "Jung"
                },
                {
                    "first": "Moon",
                    "initial": "M.",
                    "last": "Hee Kim"
                },
                {
                    "first": "Beverly L.",
                    "initial": "B.L.",
                    "last": "Davidson"
                },
                {
                    "first": "Sang",
                    "initial": "S.",
                    "last": "Kyung Lee"
                },
                {
                    "first": "Premlata",
                    "initial": "P.",
                    "last": "Shankar"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Manjunath"
                }
            ],
            "doi": "10.1038/nature05901",
            "firstpage": "39",
            "issn": "00280836",
            "lastpage": "43",
            "pmid": "17572664",
            "pub_year": 2007,
            "title": "Transvascular delivery of small interfering RNA to the central nervous system",
            "volume": "448"
        },
        "b0110": {
            "authors": [
                {
                    "first": "Ja Young",
                    "initial": "J.Y.",
                    "last": "Kim"
                },
                {
                    "first": "Won Il",
                    "initial": "W.I.",
                    "last": "Choi"
                },
                {
                    "first": "Young Ha",
                    "initial": "Y.H.",
                    "last": "Kim"
                },
                {
                    "first": "Giyoong",
                    "initial": "G.",
                    "last": "Tae"
                }
            ],
            "doi": "10.1016/j.biomaterials.2012.09.047",
            "firstpage": "1170",
            "issn": "01429612",
            "lastpage": "1178",
            "pmid": "23122677",
            "pub_year": 2013,
            "title": "Brain-targeted delivery of protein using chitosan- and RVG peptide-conjugated, pluronic-based nano-carrier",
            "volume": "34"
        },
        "b0115": null,
        "b0120": {
            "authors": [
                {
                    "first": "Lixin",
                    "initial": "L.",
                    "last": "Xiang"
                },
                {
                    "first": "Rumei",
                    "initial": "R.",
                    "last": "Zhou"
                },
                {
                    "first": "Ailing",
                    "initial": "A.",
                    "last": "Fu"
                },
                {
                    "first": "Xingran",
                    "initial": "X.",
                    "last": "Xu"
                },
                {
                    "first": "Yuqi",
                    "initial": "Y.",
                    "last": "Huang"
                },
                {
                    "first": "Changhua",
                    "initial": "C.",
                    "last": "Hu"
                }
            ],
            "doi": "10.3109/1061186X.2010.523788",
            "firstpage": "632",
            "issn": "1061186X",
            "lastpage": "636",
            "pmid": "20932231",
            "pub_year": 2011,
            "title": "Targeted delivery of large fusion protein into hippocampal neurons by systemic administration",
            "volume": "19"
        },
        "b0125": {
            "authors": [
                {
                    "first": "Ailing",
                    "initial": "A.",
                    "last": "Fu"
                },
                {
                    "first": "Yilin",
                    "initial": "Y.",
                    "last": "Wang"
                },
                {
                    "first": "Liping",
                    "initial": "L.",
                    "last": "Zhan"
                },
                {
                    "first": "Rumei",
                    "initial": "R.",
                    "last": "Zhou"
                }
            ],
            "doi": "10.1007/s11095-012-0667-y",
            "firstpage": "1562",
            "issn": "07248741",
            "lastpage": "1569",
            "pmid": "22231987",
            "pub_year": 2012,
            "title": "Targeted delivery of proteins into the central nervous system mediated by rabies virus glycoprotein-derived peptide",
            "volume": "29"
        },
        "b0130": {
            "authors": [
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "M\u00fcller"
                },
                {
                    "first": "Bernhard",
                    "initial": "B.",
                    "last": "Dietzschold"
                },
                {
                    "first": "Hildegund",
                    "initial": "H.",
                    "last": "Ertl"
                },
                {
                    "first": "Anthony R.",
                    "initial": "A.R.",
                    "last": "Fooks"
                },
                {
                    "first": "Conrad",
                    "initial": "C.",
                    "last": "Freuling"
                },
                {
                    "first": "Christine",
                    "initial": "C.",
                    "last": "Fehlner-Gardiner"
                },
                {
                    "first": "Jeannette",
                    "initial": "J.",
                    "last": "Kliemt"
                },
                {
                    "first": "Francois X.",
                    "initial": "F.X.",
                    "last": "Meslin"
                },
                {
                    "first": "Charles E.",
                    "initial": "C.E.",
                    "last": "Rupprecht"
                },
                {
                    "first": "No\u00ebl",
                    "initial": "N.",
                    "last": "Tordo"
                },
                {
                    "first": "Alexander I.",
                    "initial": "A.I.",
                    "last": "Wanderler"
                },
                {
                    "first": "Marie Paule",
                    "initial": "M.P.",
                    "last": "Kieny"
                }
            ],
            "doi": "10.1371/journal.pntd.0000542",
            "pmid": "19888334",
            "pub_year": 2009,
            "title": "Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans",
            "volume": "3"
        },
        "b0135": {
            "authors": [
                {
                    "first": "Leonard",
                    "initial": "L.",
                    "last": "Both"
                },
                {
                    "first": "Craig",
                    "initial": "C.",
                    "last": "Van Dolleweerd"
                },
                {
                    "first": "Edward",
                    "initial": "E.",
                    "last": "Wright"
                },
                {
                    "first": "Ashley C.",
                    "initial": "A.C.",
                    "last": "Banyard"
                },
                {
                    "first": "Bianca",
                    "initial": "B.",
                    "last": "Bulmer-Thomas"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Selden"
                },
                {
                    "first": "Friedrich",
                    "initial": "F.",
                    "last": "Altmann"
                },
                {
                    "first": "Anthony R.",
                    "initial": "A.R.",
                    "last": "Fooks"
                },
                {
                    "first": "Julian K.C.",
                    "initial": "J.K.C.",
                    "last": "Ma"
                }
            ],
            "doi": "10.1096/fj.12-219964",
            "firstpage": "2055",
            "issn": "15306860",
            "lastpage": "2065",
            "pmid": "23371065",
            "pub_year": 2013,
            "title": "Production, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans",
            "volume": "27"
        },
        "b0140": {
            "authors": [
                {
                    "first": "Waranyoo",
                    "initial": "W.",
                    "last": "Phoolcharoen"
                },
                {
                    "first": "Christophe",
                    "initial": "C.",
                    "last": "Prehaud"
                },
                {
                    "first": "Craig J.",
                    "initial": "C.J.",
                    "last": "van Dolleweerd"
                },
                {
                    "first": "Leonard",
                    "initial": "L.",
                    "last": "Both"
                },
                {
                    "first": "Anaelle",
                    "initial": "A.",
                    "last": "da Costa"
                },
                {
                    "first": "Monique",
                    "initial": "M.",
                    "last": "Lafon"
                },
                {
                    "first": "Julian K.C.",
                    "initial": "J.K.C.",
                    "last": "Ma"
                }
            ],
            "doi": "10.1111/pbi.12719",
            "firstpage": "1331",
            "issn": "14677644",
            "lastpage": "1339",
            "pmid": "28273388",
            "pub_year": 2017,
            "title": "Enhanced transport of plant-produced rabies single-chain antibody-RVG peptide fusion protein across an in cellulo blood\u2013brain barrier device",
            "volume": "15"
        },
        "b0145": {
            "authors": [
                {
                    "first": "Waranyoo",
                    "initial": "W.",
                    "last": "Phoolcharoen"
                },
                {
                    "first": "Christophe",
                    "initial": "C.",
                    "last": "Prehaud"
                },
                {
                    "first": "Craig J.",
                    "initial": "C.J.",
                    "last": "van Dolleweerd"
                },
                {
                    "first": "Leonard",
                    "initial": "L.",
                    "last": "Both"
                },
                {
                    "first": "Anaelle",
                    "initial": "A.",
                    "last": "da Costa"
                },
                {
                    "first": "Monique",
                    "initial": "M.",
                    "last": "Lafon"
                },
                {
                    "first": "Julian K.C.",
                    "initial": "J.K.C.",
                    "last": "Ma"
                }
            ],
            "doi": "10.1111/pbi.12719",
            "firstpage": "1331",
            "issn": "14677644",
            "lastpage": "1339",
            "pmid": "28273388",
            "pub_year": 2017,
            "title": "Enhanced transport of plant-produced rabies single-chain antibody-RVG peptide fusion protein across an in cellulo blood\u2013brain barrier device",
            "volume": "15"
        },
        "b0150": {
            "authors": [
                {
                    "first": "Zhong",
                    "initial": "Z.",
                    "last": "Huang"
                },
                {
                    "first": "Qiang",
                    "initial": "Q.",
                    "last": "Chen"
                },
                {
                    "first": "Brooke",
                    "initial": "B.",
                    "last": "Hjelm"
                },
                {
                    "first": "Charles",
                    "initial": "C.",
                    "last": "Arntzen"
                },
                {
                    "first": "Hugh",
                    "initial": "H.",
                    "last": "Mason"
                }
            ],
            "doi": "10.1002/bit.22299",
            "firstpage": "706",
            "issn": "00063592",
            "lastpage": "714",
            "pmid": "19309755",
            "pub_year": 2009,
            "title": "A DNA replicon system for rapid high-level production of virus-like particles in plants",
            "volume": "103"
        },
        "b0155": {
            "authors": [
                {
                    "first": "John G.",
                    "initial": "J.G.",
                    "last": "Yamauchi"
                },
                {
                    "first": "\u00c1kos K.",
                    "initial": "A.K.",
                    "last": "Nemecz"
                },
                {
                    "first": "Quoc Thang",
                    "initial": "Q.T.",
                    "last": "Nguyen"
                },
                {
                    "first": "Arnaud",
                    "initial": "A.",
                    "last": "Muller"
                },
                {
                    "first": "Lee F.",
                    "initial": "L.F.",
                    "last": "Schroeder"
                },
                {
                    "first": "Todd T.",
                    "initial": "T.T.",
                    "last": "Talley"
                },
                {
                    "first": "Jon",
                    "initial": "J.",
                    "last": "Lindstrom"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Kleinfeld"
                },
                {
                    "first": "Palmer",
                    "initial": "P.",
                    "last": "Taylor"
                }
            ],
            "doi": "10.1371/journal.pone.0016519",
            "issn": "19326203",
            "pmid": "21305050",
            "pub_year": 2011,
            "title": "Characterizing ligand-gated ion channel receptors with genetically encoded Ca++ sensors",
            "volume": "6"
        },
        "b0160": {
            "authors": [
                {
                    "first": "B. B.",
                    "initial": "B.B.",
                    "last": "Weksler"
                },
                {
                    "first": "E. A.",
                    "initial": "E.A.",
                    "last": "Subileau"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Perri\u00e8re"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Charneau"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Holloway"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Leveque"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Tricoire-Leignel"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Nicotra"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Bourdoulous"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Turowski"
                },
                {
                    "first": "D. K.",
                    "initial": "D.K.",
                    "last": "Male"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Roux"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Greenwood"
                },
                {
                    "first": "I. A.",
                    "initial": "I.A.",
                    "last": "Romero"
                },
                {
                    "first": "P. O.",
                    "initial": "P.O.",
                    "last": "Couraud"
                }
            ],
            "doi": "10.1096/fj.04-3458fje",
            "firstpage": "1872",
            "issn": "08926638",
            "lastpage": "1874",
            "pmid": "16141364",
            "pub_year": 2005,
            "title": "Blood-brain barrier-specific properties of a human adult brain endothelial cell line",
            "volume": "19"
        },
        "b0165": {
            "authors": [
                {
                    "first": "Maria Isabel",
                    "initial": "M.I.",
                    "last": "Thoulouze"
                },
                {
                    "first": "Mireille",
                    "initial": "M.",
                    "last": "Lafage"
                },
                {
                    "first": "Juan Antonio",
                    "initial": "J.A.",
                    "last": "Montano-Hirose"
                },
                {
                    "first": "Monique",
                    "initial": "M.",
                    "last": "Lafon"
                }
            ],
            "doi": "10.1128/jvi.71.10.7372-7380.1997",
            "firstpage": "7372",
            "issn": "0022538X",
            "lastpage": "7380",
            "pmid": "9311815",
            "pub_year": 1997,
            "title": "Rabies virus infects mouse and human lymphocytes and induces apoptosis",
            "volume": "71"
        },
        "b0170": {
            "authors": [
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "M\u00e9gret"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Prehaud"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Lafage"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Batejat"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Escriou"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Lay"
                },
                {
                    "first": "M. I.",
                    "initial": "M.I.",
                    "last": "Thoulouze"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Lafon"
                }
            ],
            "doi": "10.1016/j.vaccine.2005.06.027",
            "firstpage": "5342",
            "issn": "0264410X",
            "lastpage": "5350",
            "pmid": "16054731",
            "pub_year": 2005,
            "title": "Immunopotentiation of the antibody response against influenza HA with apoptotic bodies generated by rabies virus G-ERA protein-driven apoptosis",
            "volume": "23"
        },
        "b0175": {
            "authors": [
                {
                    "first": "Daniela E.",
                    "initial": "D.E.",
                    "last": "Eigenmann"
                },
                {
                    "first": "Gongda",
                    "initial": "G.",
                    "last": "Xue"
                },
                {
                    "first": "Kwang S.",
                    "initial": "K.S.",
                    "last": "Kim"
                },
                {
                    "first": "Ashlee V.",
                    "initial": "A.V.",
                    "last": "Moses"
                },
                {
                    "first": "Matthias",
                    "initial": "M.",
                    "last": "Hamburger"
                },
                {
                    "first": "Mouhssin",
                    "initial": "M.",
                    "last": "Oufir"
                }
            ],
            "doi": "10.1186/2045-8118-10-33",
            "issn": "20458118",
            "pub_year": 2013,
            "title": "Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studies",
            "volume": "10"
        },
        "b0180": {
            "authors": [
                {
                    "first": "Kinjiro",
                    "initial": "K.",
                    "last": "Morimoto"
                },
                {
                    "first": "Menal",
                    "initial": "M.",
                    "last": "Patel"
                },
                {
                    "first": "Susanne",
                    "initial": "S.",
                    "last": "Corisdeo"
                },
                {
                    "first": "D. Craig",
                    "initial": "D.C.",
                    "last": "Hooper"
                },
                {
                    "first": "Zhen Fang",
                    "initial": "Z.F.",
                    "last": "Fu"
                },
                {
                    "first": "Charles E.",
                    "initial": "C.E.",
                    "last": "Rupprecht"
                },
                {
                    "first": "Hilary",
                    "initial": "H.",
                    "last": "Koprowski"
                },
                {
                    "first": "Bernhard",
                    "initial": "B.",
                    "last": "Dietzschold"
                }
            ],
            "doi": "10.1073/pnas.93.11.5653",
            "firstpage": "5653",
            "issn": "00278424",
            "lastpage": "5658",
            "pmid": "8643632",
            "pub_year": 1996,
            "title": "Characterization of a unique variant of bat rabies virus responsible for newly emerging human cases in North America",
            "volume": "93"
        },
        "b0185": {
            "authors": [
                {
                    "first": "Eleni",
                    "initial": "E.",
                    "last": "Markoutsa"
                },
                {
                    "first": "Georgios",
                    "initial": "G.",
                    "last": "Pampalakis"
                },
                {
                    "first": "Anna",
                    "initial": "A.",
                    "last": "Niarakis"
                },
                {
                    "first": "Ignacio A.",
                    "initial": "I.A.",
                    "last": "Romero"
                },
                {
                    "first": "Babette",
                    "initial": "B.",
                    "last": "Weksler"
                },
                {
                    "first": "Pierre Olivier",
                    "initial": "P.O.",
                    "last": "Couraud"
                },
                {
                    "first": "Sophia G.",
                    "initial": "S.G.",
                    "last": "Antimisiaris"
                }
            ],
            "doi": "10.1016/j.ejpb.2010.11.015",
            "firstpage": "265",
            "issn": "09396411",
            "lastpage": "274",
            "pmid": "21118722",
            "pub_year": 2011,
            "title": "Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line",
            "volume": "77"
        },
        "b0190": {
            "authors": [
                {
                    "first": "Jaap",
                    "initial": "J.",
                    "last": "Rip"
                }
            ],
            "doi": "10.1016/j.ddtec.2016.07.005",
            "firstpage": "53",
            "issn": "17406749",
            "lastpage": "58",
            "pmid": "27986225",
            "pub_year": 2016,
            "title": "Liposome technologies and drug delivery to the CNS",
            "volume": "20"
        },
        "b0195": {
            "authors": [
                {
                    "first": "Corinne",
                    "initial": "C.",
                    "last": "Portioli"
                },
                {
                    "first": "Michele",
                    "initial": "M.",
                    "last": "Bovi"
                },
                {
                    "first": "Donatella",
                    "initial": "D.",
                    "last": "Benati"
                },
                {
                    "first": "Marta",
                    "initial": "M.",
                    "last": "Donini"
                },
                {
                    "first": "Massimiliano",
                    "initial": "M.",
                    "last": "Perduca"
                },
                {
                    "first": "Alessandro",
                    "initial": "A.",
                    "last": "Romeo"
                },
                {
                    "first": "Stefano",
                    "initial": "S.",
                    "last": "Dusi"
                },
                {
                    "first": "Hugo L.",
                    "initial": "H.L.",
                    "last": "Monaco"
                },
                {
                    "first": "Marina",
                    "initial": "M.",
                    "last": "Bentivoglio"
                }
            ],
            "doi": "10.1002/jbm.a.35961",
            "firstpage": "847",
            "issn": "15493296",
            "lastpage": "858",
            "pmid": "27885823",
            "pub_year": 2017,
            "title": "Novel functionalization strategies of polymeric nanoparticles as carriers for brain medications",
            "volume": "105"
        },
        "b0200": {
            "authors": [
                {
                    "first": "Xin",
                    "initial": "X.",
                    "last": "Meng"
                },
                {
                    "first": "Jiansheng",
                    "initial": "J.",
                    "last": "Liu"
                },
                {
                    "first": "Xiangrong",
                    "initial": "X.",
                    "last": "Yu"
                },
                {
                    "first": "Jiajia",
                    "initial": "J.",
                    "last": "Li"
                },
                {
                    "first": "Xiaotong",
                    "initial": "X.",
                    "last": "Lu"
                },
                {
                    "first": "Teng",
                    "initial": "T.",
                    "last": "Shen"
                }
            ],
            "doi": "10.1038/s41598-017-03123-y",
            "issn": "20452322",
            "pmid": "28592843",
            "pub_year": 2017,
            "title": "Pluronic F127 and D-\u03b1-Tocopheryl Polyethylene Glycol Succinate (TPGS) Mixed Micelles for Targeting Drug Delivery across The Blood Brain Barrier",
            "volume": "7"
        },
        "b0205": {
            "authors": [
                {
                    "first": "Ching Hao",
                    "initial": "C.H.",
                    "last": "Li"
                },
                {
                    "first": "Ming Kwang",
                    "initial": "M.K.",
                    "last": "Shyu"
                },
                {
                    "first": "Cheng",
                    "initial": "C.",
                    "last": "Jhan"
                },
                {
                    "first": "Yu Wen",
                    "initial": "Y.W.",
                    "last": "Cheng"
                },
                {
                    "first": "Chi Hao",
                    "initial": "C.H.",
                    "last": "Tsai"
                },
                {
                    "first": "Chen Wei",
                    "initial": "C.W.",
                    "last": "Liu"
                },
                {
                    "first": "Chen Chen",
                    "initial": "C.C.",
                    "last": "Lee"
                },
                {
                    "first": "Ruei Ming",
                    "initial": "R.M.",
                    "last": "Chen"
                },
                {
                    "first": "Jaw Jou",
                    "initial": "J.J.",
                    "last": "Kang"
                }
            ],
            "doi": "10.1093/toxsci/kfv176",
            "firstpage": "192",
            "issn": "10966080",
            "lastpage": "203",
            "pmid": "26272951",
            "pub_year": 2015,
            "title": "Gold nanoparticles increase endothelial paracellular permeability by altering components of endothelial tight junctions, and increase blood-brain barrier permeability in mice",
            "volume": "148"
        },
        "b0210": {
            "authors": [
                {
                    "first": "Ruben J.",
                    "initial": "R.J.",
                    "last": "Boado"
                },
                {
                    "first": "Qing Hui",
                    "initial": "Q.H.",
                    "last": "Zhou"
                },
                {
                    "first": "Jeff Zhiqiang",
                    "initial": "J.Z.",
                    "last": "Lu"
                },
                {
                    "first": "Eric Ka Wai",
                    "initial": "E.K.W.",
                    "last": "Hui"
                },
                {
                    "first": "William M.",
                    "initial": "W.M.",
                    "last": "Pardridge"
                }
            ],
            "doi": "10.1021/mp900235k",
            "firstpage": "237",
            "issn": "15438384",
            "lastpage": "244",
            "pmid": "19921848",
            "pub_year": 2010,
            "title": "Pharmacokinetics and brain uptake of a genetically engineered bifunctional fusion antibody targeting the mouse transferrin receptor",
            "volume": "7"
        },
        "b0215": {
            "authors": [
                {
                    "first": "Jens",
                    "initial": "J.",
                    "last": "Niewoehner"
                },
                {
                    "first": "Bernd",
                    "initial": "B.",
                    "last": "Bohrmann"
                },
                {
                    "first": "Ludovic",
                    "initial": "L.",
                    "last": "Collin"
                },
                {
                    "first": "Eduard",
                    "initial": "E.",
                    "last": "Urich"
                },
                {
                    "first": "Hadassah",
                    "initial": "H.",
                    "last": "Sade"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Maier"
                },
                {
                    "first": "Petra",
                    "initial": "P.",
                    "last": "Rueger"
                },
                {
                    "first": "Jan Olaf",
                    "initial": "J.O.",
                    "last": "Stracke"
                },
                {
                    "first": "Wilma",
                    "initial": "W.",
                    "last": "Lau"
                },
                {
                    "first": "Alain C.",
                    "initial": "A.C.",
                    "last": "Tissot"
                },
                {
                    "first": "Hansruedi",
                    "initial": "H.",
                    "last": "Loetscher"
                },
                {
                    "first": "Anirvan",
                    "initial": "A.",
                    "last": "Ghosh"
                },
                {
                    "first": "Per Ola",
                    "initial": "P.O.",
                    "last": "Freskg\u00e5rd"
                }
            ],
            "doi": "10.1016/j.neuron.2013.10.061",
            "firstpage": "49",
            "issn": "08966273",
            "lastpage": "60",
            "pmid": "24411731",
            "pub_year": 2014,
            "title": "Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle",
            "volume": "81"
        },
        "b0220": {
            "authors": [
                {
                    "first": "Nga",
                    "initial": "N.",
                    "last": "Bien-Ly"
                },
                {
                    "first": "Y. Joy",
                    "initial": "Y.J.",
                    "last": "Yu"
                },
                {
                    "first": "Daniela",
                    "initial": "D.",
                    "last": "Bumbaca"
                },
                {
                    "first": "Justin",
                    "initial": "J.",
                    "last": "Elstrott"
                },
                {
                    "first": "C. Andrew",
                    "initial": "C.A.",
                    "last": "Boswell"
                },
                {
                    "first": "Yin",
                    "initial": "Y.",
                    "last": "Zhang"
                },
                {
                    "first": "Wilman",
                    "initial": "W.",
                    "last": "Luk"
                },
                {
                    "first": "Yanmei",
                    "initial": "Y.",
                    "last": "Lu"
                },
                {
                    "first": "Mark S.",
                    "initial": "M.S.",
                    "last": "Dennis"
                },
                {
                    "first": "Robby M.",
                    "initial": "R.M.",
                    "last": "Weimer"
                },
                {
                    "first": "Inhee",
                    "initial": "I.",
                    "last": "Chung"
                },
                {
                    "first": "Ryan J.",
                    "initial": "R.J.",
                    "last": "Watts"
                }
            ],
            "doi": "10.1084/jem.20131660",
            "firstpage": "233",
            "issn": "00221007",
            "lastpage": "244",
            "pmid": "24470444",
            "pub_year": 2014,
            "title": "Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants",
            "volume": "211"
        },
        "b0225": {
            "authors": [
                {
                    "first": "William M.",
                    "initial": "W.M.",
                    "last": "Pardridge"
                },
                {
                    "first": "Young Sook",
                    "initial": "Y.S.",
                    "last": "Kang"
                },
                {
                    "first": "Jody L.",
                    "initial": "J.L.",
                    "last": "Buciak"
                },
                {
                    "first": "Jing",
                    "initial": "J.",
                    "last": "Yang"
                }
            ],
            "doi": "10.1023/A:1016244500596",
            "firstpage": "807",
            "issn": "07248741",
            "lastpage": "816",
            "pmid": "7667183",
            "pub_year": 1995,
            "title": "Human Insulin Receptor Monoclonal Antibody Undergoes High Affinity Binding to Human Brain Capillaries in Vitro and Rapid Transcytosis Through the Blood\u2013Brain Barrier in Vivo in the Primate",
            "volume": "12"
        },
        "b0230": {
            "authors": [
                {
                    "first": "Ruben J.",
                    "initial": "R.J.",
                    "last": "Boado"
                },
                {
                    "first": "Yun",
                    "initial": "Y.",
                    "last": "Zhang"
                },
                {
                    "first": "Yufeng",
                    "initial": "Y.",
                    "last": "Zhang"
                },
                {
                    "first": "Chun Fang",
                    "initial": "C.F.",
                    "last": "Xia"
                },
                {
                    "first": "Yuntao",
                    "initial": "Y.",
                    "last": "Wang"
                },
                {
                    "first": "William M.",
                    "initial": "W.M.",
                    "last": "Pardridge"
                }
            ],
            "doi": "10.1002/bit.21602",
            "firstpage": "475",
            "issn": "00063592",
            "lastpage": "484",
            "pmid": "17680664",
            "pub_year": 2008,
            "title": "Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood-brain barrier",
            "volume": "99"
        },
        "b0235": {
            "authors": [
                {
                    "first": "Xiaohe",
                    "initial": "X.",
                    "last": "Tian"
                },
                {
                    "first": "Sophie",
                    "initial": "S.",
                    "last": "Nyberg"
                },
                {
                    "first": "Paul S.",
                    "initial": "P.S.",
                    "last": "Sharp"
                },
                {
                    "first": "Jeppe",
                    "initial": "J.",
                    "last": "Madsen"
                },
                {
                    "first": "Nooshin",
                    "initial": "N.",
                    "last": "Daneshpour"
                },
                {
                    "first": "Steven P.",
                    "initial": "S.P.",
                    "last": "Armes"
                },
                {
                    "first": "Jason",
                    "initial": "J.",
                    "last": "Berwick"
                },
                {
                    "first": "Mimoun",
                    "initial": "M.",
                    "last": "Azzouz"
                },
                {
                    "first": "Pamela",
                    "initial": "P.",
                    "last": "Shaw"
                },
                {
                    "first": "N. Joan",
                    "initial": "N.J.",
                    "last": "Abbott"
                },
                {
                    "first": "Giuseppe",
                    "initial": "G.",
                    "last": "Battaglia"
                }
            ],
            "doi": "10.1038/srep11990",
            "issn": "20452322",
            "pmid": "26189707",
            "pub_year": 2015,
            "title": "LRP-1-mediated intracellular antibody delivery to the Central Nervous System",
            "volume": "5"
        },
        "b0240": {
            "authors": [
                {
                    "first": "Mie",
                    "initial": "M.",
                    "last": "Kristensen"
                },
                {
                    "first": "Birger",
                    "initial": "B.",
                    "last": "Brodin"
                }
            ],
            "doi": "10.1016/j.xphs.2017.04.080",
            "firstpage": "2326",
            "issn": "00223549",
            "lastpage": "2334",
            "pmid": "28501469",
            "pub_year": 2017,
            "title": "Routes for Drug Translocation Across the Blood-Brain Barrier: Exploiting Peptides as Delivery Vectors",
            "volume": "106"
        },
        "b0245": {
            "authors": [
                {
                    "first": "Dongdong",
                    "initial": "D.",
                    "last": "Zhang"
                },
                {
                    "first": "Jiaxi",
                    "initial": "J.",
                    "last": "Wang"
                },
                {
                    "first": "Donggang",
                    "initial": "D.",
                    "last": "Xu"
                }
            ],
            "doi": "10.1016/j.jconrel.2016.03.020",
            "firstpage": "130",
            "issn": "01683659",
            "lastpage": "139",
            "pmid": "26993425",
            "pub_year": 2016,
            "title": "Cell-penetrating peptides as noninvasive transmembrane vectors for the development of novel multifunctional drug-delivery systems",
            "volume": "229"
        },
        "b0250": {
            "authors": [
                {
                    "first": "Carolina",
                    "initial": "C.",
                    "last": "Velasco-Aguirre"
                },
                {
                    "first": "Francisco",
                    "initial": "F.",
                    "last": "Morales"
                },
                {
                    "first": "Eduardo",
                    "initial": "E.",
                    "last": "Gallardo-Toledo"
                },
                {
                    "first": "Simon",
                    "initial": "S.",
                    "last": "Guerrero"
                },
                {
                    "first": "Ernest",
                    "initial": "E.",
                    "last": "Giralt"
                },
                {
                    "first": "Eyleen",
                    "initial": "E.",
                    "last": "Araya"
                },
                {
                    "first": "Marcelo J.",
                    "initial": "M.J.",
                    "last": "Kogan"
                }
            ],
            "doi": "10.2147/IJN.S82310",
            "firstpage": "4919",
            "issn": "11769114",
            "lastpage": "4936",
            "pmid": "26300639",
            "pub_year": 2015,
            "title": "Peptides and proteins used to enhance gold nanoparticle delivery to the brain: Preclinical approaches",
            "volume": "10"
        },
        "b0255": null,
        "b0260": {
            "authors": [
                {
                    "first": "Audrey Y.H.",
                    "initial": "A.Y.H.",
                    "last": "Teh"
                },
                {
                    "first": "Daniel",
                    "initial": "D.",
                    "last": "Maresch"
                },
                {
                    "first": "Katja",
                    "initial": "K.",
                    "last": "Klein"
                },
                {
                    "first": "Julian K.C.",
                    "initial": "J.K.C.",
                    "last": "Ma"
                }
            ],
            "doi": "10.1111/pbi.12137",
            "firstpage": "300",
            "issn": "14677644",
            "lastpage": "311",
            "pmid": "24256218",
            "pub_year": 2014,
            "title": "Characterization of VRC01, a potent and broadly neutralizing anti-HIV mAb, produced in transiently and stably transformed tobacco",
            "volume": "12"
        },
        "b0265": {
            "authors": [
                {
                    "first": "D. L.",
                    "initial": "D.L.",
                    "last": "Donnelly-Roberts"
                },
                {
                    "first": "T. L.",
                    "initial": "T.L.",
                    "last": "Lentz"
                }
            ],
            "firstpage": "221",
            "issn": "10405704",
            "lastpage": "226",
            "pmid": "2520759",
            "pub_year": 1989,
            "title": "Synthetic peptides of neurotoxins and rabies virus glycoprotein behave as antagonists in a functional assay for the acetylcholine receptor.",
            "volume": "2"
        },
        "b0270": {
            "authors": [
                {
                    "first": "M. J.",
                    "initial": "M.J.",
                    "last": "Warrell"
                }
            ],
            "doi": "10.1111/tmi.12668",
            "firstpage": "456",
            "issn": "13602276",
            "lastpage": "457",
            "pmid": "26799263",
            "pub_year": 2016,
            "title": "The dilemma of managing human rabies encephalitis",
            "volume": "21"
        },
        "b0275": {
            "authors": [
                {
                    "first": "Jan Terje",
                    "initial": "J.T.",
                    "last": "Andersen"
                },
                {
                    "first": "Muluneh Bekele",
                    "initial": "M.B.",
                    "last": "Daba"
                },
                {
                    "first": "G\u00f8ril",
                    "initial": "G.",
                    "last": "Berntzen"
                },
                {
                    "first": "Terje E.",
                    "initial": "T.E.",
                    "last": "Michaelsen"
                },
                {
                    "first": "Inger",
                    "initial": "I.",
                    "last": "Sandlie"
                }
            ],
            "doi": "10.1074/jbc.M109.081828",
            "firstpage": "4826",
            "issn": "00219258",
            "lastpage": "4836",
            "pmid": "20018855",
            "pub_year": 2010,
            "title": "Cross-species binding analyses of mouse and human neonatal Fc receptor show dramatic differences in immunoglobulin G and albumin binding",
            "volume": "285"
        }
    },
    "body_text": [
        {
            "endOffset": 35842,
            "parents": [],
            "refoffsets": {
                "b0260": {
                    "endOffset": 35841,
                    "startOffset": 35837
                }
            },
            "secId": "s0075",
            "sentence": "By comparison, IgG antibodies are currently being developed that express in Nicotiana in the range of 100 mg/kg fresh leaf weight [52].",
            "startOffset": 35707,
            "title": "Discussion"
        },
        {
            "endOffset": 18207,
            "parents": [],
            "refoffsets": {
                "b0010": {
                    "endOffset": 18206,
                    "startOffset": 18203
                }
            },
            "secId": "s0005",
            "sentence": "Lyssaviruses are strongly neurotrophic, however, replication in the musculature, prior to entry into the peripheral nervous system occurs, and is likely to contribute to the variation in incubation times seen following infection [2].",
            "startOffset": 17974,
            "title": "Introduction"
        },
        {
            "endOffset": 20899,
            "parents": [],
            "secId": "s0005",
            "sentence": "In the latter study, a fusion protein comprising ScFv linked to the RVG peptide at its C-terminus was expressed and shown to neutralise RABV, bind to nAchR and transport across a model BBB.",
            "startOffset": 20710,
            "title": "Introduction"
        },
        {
            "endOffset": 17973,
            "parents": [],
            "secId": "s0005",
            "sentence": "The mechanism of virus infection once it has crossed the dermal barrier is poorly defined.",
            "startOffset": 17883,
            "title": "Introduction"
        },
        {
            "endOffset": 20709,
            "parents": [],
            "refoffsets": {
                "b0130": {
                    "endOffset": 20499,
                    "startOffset": 20495
                },
                "b0135": {
                    "endOffset": 20684,
                    "startOffset": 20680
                },
                "b0140": {
                    "endOffset": 20708,
                    "startOffset": 20704
                }
            },
            "secId": "s0005",
            "sentence": "Previous studies have described the application of monoclonal antibody preparations as an alternative to RIG [26], generation of monoclonal antibodies in planta and expression of a single chain antibody fragment (ScFv) of a previously defined rabies neutralising monoclonal antibody in E. coli [27] and N. benthamiana [28].",
            "startOffset": 20386,
            "title": "Introduction"
        },
        {
            "endOffset": 19717,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 19716,
                    "startOffset": 19712
                }
            },
            "secId": "s0005",
            "sentence": "The size exclusion limit is approximately 10 kD [13].",
            "startOffset": 19664,
            "title": "Introduction"
        },
        {
            "endOffset": 40019,
            "parents": [],
            "secId": "s0075",
            "sentence": "A definitive pre-clinical study demonstrating protective efficacy in a robust model for central nervous system infection by rabies virus is now required.",
            "startOffset": 39866,
            "title": "Discussion"
        },
        {
            "endOffset": 19962,
            "parents": [],
            "refoffsets": {
                "b0070": {
                    "endOffset": 19873,
                    "startOffset": 19869
                },
                "b0075": {
                    "endOffset": 19961,
                    "startOffset": 19957
                }
            },
            "secId": "s0005",
            "sentence": "Rabies glycoprotein (G), present as a trimeric peplomer on the viral envelope, contains a short conserved motif which serves to bind cellular receptors [14], including nicotinic acetylcholine receptors (nAchRs), to mediate entry into cells [15].",
            "startOffset": 19717,
            "title": "Introduction"
        },
        {
            "endOffset": 24733,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "For the binding assay, samples were washed 3 times with 1% inactivated foetal calf serum (0.1% NaN3) in PBS, pH 7.4.",
            "startOffset": 24617,
            "title": "nAchR binding and competition assay"
        },
        {
            "endOffset": 27764,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "The treatments were initiated either four hours before virus inoculation (\u22124hr), two days (+2d) after virus infection or 4 days (+4d) after virus inoculation.",
            "startOffset": 27606,
            "title": "In vivo assessment of ScFV/RVG"
        },
        {
            "endOffset": 21705,
            "parents": [],
            "secId": "s0005",
            "sentence": "Direct in vivo comparisons with the action of HRIG demonstrated that ScFv/RVG may have future utility as a post-exposure alternative to HRIG for rabies virus post exposure treatment.",
            "startOffset": 21523,
            "title": "Introduction"
        },
        {
            "endOffset": 32546,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Similarly, a 62-71-3 IgG/RVG conjugate was also unable to cross the monolayer.",
            "startOffset": 32468,
            "title": "Passage of ScFv/RVG conjugate across an in vitro model of the blood brain barrier"
        },
        {
            "endOffset": 37283,
            "parents": [],
            "secId": "s0075",
            "sentence": "This model was impermeable to the full length 62-71-3 IgG mAb as expected.",
            "startOffset": 37209,
            "title": "Discussion"
        },
        {
            "endOffset": 24616,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "The cells were washed with PBS, then harvested into FACS tubes and incubated in cell fixation solution (BD Biosciences, USA) for 15 min.",
            "startOffset": 24480,
            "title": "nAchR binding and competition assay"
        },
        {
            "endOffset": 23001,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "After 2 h, the protein was dialyzed in PBS overnight.",
            "startOffset": 22948,
            "title": "ScFv and ScFv/RVG production"
        },
        {
            "endOffset": 37743,
            "parents": [],
            "secId": "s0075",
            "sentence": "The increasing concentration of neutralising activity in the lower chamber of this assay with time, in comparison with the result using unconjugated ScFv alone, suggests that transport was mediated by an active mechanism.",
            "startOffset": 37522,
            "title": "Discussion"
        },
        {
            "endOffset": 23797,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Bands were visualised following addition of ECL plus detection reagent (GE Healthcare, UK).",
            "startOffset": 23706,
            "title": "SDS-PAGE and western blot"
        },
        {
            "endOffset": 20386,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 20284,
                    "startOffset": 20280
                },
                "b0110": {
                    "endOffset": 20307,
                    "startOffset": 20300
                },
                "b0115": {
                    "endOffset": 20307,
                    "startOffset": 20300
                },
                "b0120": {
                    "endOffset": 20328,
                    "startOffset": 20321
                },
                "b0125": {
                    "endOffset": 20328,
                    "startOffset": 20321
                }
            },
            "secId": "s0005",
            "sentence": "The identification of a key 29 amino acid peptide in G responsible for binding and entry into neuronal cells led to the demonstration that other molecules (siRNA) [21], nanoparticles [22,23], and enzymes [24,25]] could be delivered to the CNS if linked to this peptide.",
            "startOffset": 20117,
            "title": "Introduction"
        },
        {
            "endOffset": 22035,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0135": {
                    "endOffset": 21984,
                    "startOffset": 21980
                },
                "b0140": {
                    "endOffset": 22007,
                    "startOffset": 22003
                }
            },
            "secId": "s0015",
            "sentence": "Agrobacterium tumefaciens LBA4404 was separately transformed with the pEAQ-62-71-3 IgG [27] and the pEAQ-ScFV [28] vectors by electroporation.",
            "startOffset": 21893,
            "title": "ScFv and ScFv/RVG production"
        },
        {
            "endOffset": 21252,
            "parents": [],
            "secId": "s0005",
            "sentence": "The ScFv/RVG conjugate retained the ability to neutralise RABV.",
            "startOffset": 21189,
            "title": "Introduction"
        },
        {
            "endOffset": 23079,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The reaction feed was 50% peptide and 50% ScFv, and the molar ratio was 18:1.",
            "startOffset": 23002,
            "title": "ScFv and ScFv/RVG production"
        },
        {
            "endOffset": 34861,
            "parents": [],
            "refoffsets": {
                "b0240": {
                    "endOffset": 34860,
                    "startOffset": 34853
                },
                "b0245": {
                    "endOffset": 34860,
                    "startOffset": 34853
                },
                "b0250": {
                    "endOffset": 34860,
                    "startOffset": 34853
                }
            },
            "secId": "s0075",
            "sentence": "Peptides have also gained attention for their potential to mediate delivery across the BBB [48\u201350].",
            "startOffset": 34762,
            "title": "Discussion"
        },
        {
            "endOffset": 39865,
            "parents": [],
            "secId": "s0075",
            "sentence": "This study did however, confirm the protective property of ScFv/RVG in vivo, and demonstrates that the chemical conjugation process does not affect the viral neutralisation properties of the ScFv in vivo.",
            "startOffset": 39661,
            "title": "Discussion"
        },
        {
            "endOffset": 33676,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Among the four treatments ScFv/RVG, T-705, ScFv/RVG with T-705 and HRIG, the estimated effect on logit mortality from treating at 2d relative to \u22124h = 0 (95% confidence interval \u22121.08 to 1.08); 4d relative to \u22124h = \u22120.16 (\u22121.26 to 0.94).",
            "startOffset": 33439,
            "title": "In vivo assessment of ScFv/RVG"
        },
        {
            "endOffset": 17762,
            "parents": [],
            "secId": "s0005",
            "sentence": "The genome encodes five proteins including nucleoprotein, phosphoprotein, matrix protein, glycoprotein, and RNA polymerase.",
            "startOffset": 17639,
            "title": "Introduction"
        },
        {
            "endOffset": 26243,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0145": {
                    "endOffset": 26242,
                    "startOffset": 26238
                }
            },
            "secId": "s0035",
            "sentence": "The restrictive paracellular permeability of hCMEC/D3 cells was assessed by their low permeability to the non-permeant fluorescent marker Lucifer Yellow (LY) [29].",
            "startOffset": 26080,
            "title": "In vitro BBB transwell assay"
        },
        {
            "endOffset": 37393,
            "parents": [],
            "secId": "s0075",
            "sentence": "Conjugating RVG to 62-71-3 IgG made no difference, indicating that that the size of IgG is a limiting factor.",
            "startOffset": 37284,
            "title": "Discussion"
        },
        {
            "endOffset": 25889,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0175": {
                    "endOffset": 25888,
                    "startOffset": 25884
                }
            },
            "secId": "s0035",
            "sentence": "An immortalized human brain capillary endothelial cell line (hCMEC/D3) was kindly provided by Prof. Pierre-Olivier Couraud (Institut Cochin, Universit\u00e9 Ren\u00e9 Descartes, Paris, France) and Prof. Pierre-Emmanuel Ceccaldi (Institut Pasteur, Paris) [35].",
            "startOffset": 25640,
            "title": "In vitro BBB transwell assay"
        },
        {
            "endOffset": 30062,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Again, this band is the major component of the preparation.",
            "startOffset": 30003,
            "title": "Characterisation of the 62-71-3 ScFv and the ScFv/RVG conjugate"
        },
        {
            "endOffset": 29846,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "A full size ScFv is detected predominantly at approximately 56 kDa, which was the major band detected.",
            "startOffset": 29744,
            "title": "Characterisation of the 62-71-3 ScFv and the ScFv/RVG conjugate"
        },
        {
            "endOffset": 31632,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "No effect of either irradiated virus or \u03b1-bungarotoxin was observed in the case of ScFv (Fig. 4A and C, respectively).",
            "startOffset": 31514,
            "title": "Binding to nAchR and cell entry"
        },
        {
            "endOffset": 34761,
            "parents": [],
            "refoffsets": {
                "b0210": {
                    "endOffset": 34689,
                    "startOffset": 34682
                },
                "b0215": {
                    "endOffset": 34689,
                    "startOffset": 34682
                },
                "b0220": {
                    "endOffset": 34689,
                    "startOffset": 34682
                },
                "b0225": {
                    "endOffset": 34715,
                    "startOffset": 34708
                },
                "b0230": {
                    "endOffset": 34715,
                    "startOffset": 34708
                },
                "b0235": {
                    "endOffset": 34760,
                    "startOffset": 34756
                }
            },
            "secId": "s0075",
            "sentence": "Examples include antibodies against the transferrin receptor [42\u201344], insulin receptor [45,46] or the low density lipoprotein receptor [47].",
            "startOffset": 34621,
            "title": "Discussion"
        },
        {
            "endOffset": 39128,
            "parents": [],
            "secId": "s0075",
            "sentence": "Although the dosages administered were equivalent in terms of International Units/kg, ScFv/RVG performed less effectively than HRIG.",
            "startOffset": 38996,
            "title": "Discussion"
        },
        {
            "endOffset": 25526,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0170": {
                    "endOffset": 25413,
                    "startOffset": 25409
                }
            },
            "secId": "s0030",
            "sentence": "For the competition assay, cells were pretreated on ice with either 2 \u00d7 107 PFU of UV inactivated Rabies virus (CVS) [34] or 16 \u03bcM alpha bungarotoxin (Tocris Bioscience, UK) for 30 min, before the ScFv or ScFv/RVG conjugate was added.",
            "startOffset": 25292,
            "title": "nAchR binding and competition assay"
        },
        {
            "endOffset": 37923,
            "parents": [],
            "secId": "s0075",
            "sentence": "An in vivo assessment of ScFv/RVG was subsequently attempted using a murine model of rabies virus infection and different treatment schedules with either HRIG or the ScFv molecule.",
            "startOffset": 37743,
            "title": "Discussion"
        },
        {
            "endOffset": 35010,
            "parents": [],
            "secId": "s0075",
            "sentence": "The rabies virus glycoprotein (RVG) peptide used in this study binds specifically to the acetylcholine receptor (nAchR) expressed on neuronal cells.",
            "startOffset": 34862,
            "title": "Discussion"
        },
        {
            "endOffset": 32275,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "After addition of antibodies to the upper chamber, the media in the lower chamber was tested for rabies virus neutralizing activity after incubation periods of 2 and 18 h (Fig. 5).",
            "startOffset": 32095,
            "title": "Passage of ScFv/RVG conjugate across an in vitro model of the blood brain barrier"
        },
        {
            "endOffset": 18323,
            "parents": [],
            "refoffsets": {
                "b0015": {
                    "endOffset": 18322,
                    "startOffset": 18319
                }
            },
            "secId": "s0005",
            "sentence": "Whilst the prodrome generally lasts for 3\u201310 weeks, significantly longer incubation periods have been reported [3].",
            "startOffset": 18208,
            "title": "Introduction"
        },
        {
            "endOffset": 18964,
            "parents": [],
            "refoffsets": {
                "b0030": {
                    "endOffset": 18963,
                    "startOffset": 18958
                },
                "b0035": {
                    "endOffset": 18963,
                    "startOffset": 18958
                },
                "b0040": {
                    "endOffset": 18963,
                    "startOffset": 18958
                },
                "b0045": {
                    "endOffset": 18963,
                    "startOffset": 18958
                }
            },
            "secId": "s0005",
            "sentence": "Rabies post-exposure prophylaxis (PEP) is highly effective if administered in a timely manner following exposure [6\u20139].",
            "startOffset": 18845,
            "title": "Introduction"
        },
        {
            "endOffset": 24129,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0160": {
                    "endOffset": 24022,
                    "startOffset": 24018
                }
            },
            "secId": "s0025",
            "sentence": "The immortalized human brain capillary endothelial cell line (hCMEC/D3) [32] was purchased from Tebu Bio (France) and the cells were grown according to the manufacturer\u2019s instruction.",
            "startOffset": 23946,
            "title": "Cells and viruses"
        },
        {
            "endOffset": 24231,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0165": {
                    "endOffset": 24174,
                    "startOffset": 24170
                }
            },
            "secId": "s0025",
            "sentence": "Silver Haired Bat rabies variant (SHBV) [33] was used for the rabies virus pathogenicity experiments.",
            "startOffset": 24130,
            "title": "Cells and viruses"
        },
        {
            "endOffset": 17882,
            "parents": [],
            "secId": "s0005",
            "sentence": "RABV is almost always transmitted following a bite injury from an infected animal that is excreting virus in its saliva.",
            "startOffset": 17762,
            "title": "Introduction"
        },
        {
            "endOffset": 33282,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "There was a clear trend showing greatest mortality in PBS treated groups, compared with those treated with HRIG (lowest) and ScFv/RVG (Figs. 6, 7).",
            "startOffset": 33135,
            "title": "In vivo assessment of ScFv/RVG"
        },
        {
            "endOffset": 38179,
            "parents": [],
            "secId": "s0075",
            "sentence": "For this experiment, treatment schedules were designed on the hypothesis that at 4 h before inoculation and 2 days post inoculation, the infecting virus would still be in the periphery and that an established neuronal infection had not yet been initiated.",
            "startOffset": 37924,
            "title": "Discussion"
        },
        {
            "endOffset": 30915,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "The binding and penetration of ScFv and ScFv/RVG conjugate in HEK 293 cells overexpressing nAchR were tested by flow cytometry.",
            "startOffset": 30788,
            "title": "Binding to nAchR and cell entry"
        },
        {
            "endOffset": 37521,
            "parents": [],
            "secId": "s0075",
            "sentence": "Although there was some apparent passage of ScFv across the BBB model, this was significantly enhanced in the case of ScFv/RVG.",
            "startOffset": 37394,
            "title": "Discussion"
        },
        {
            "endOffset": 19663,
            "parents": [],
            "secId": "s0005",
            "sentence": "Rabies virus antibodies, such as RIG are unlikely to offer therapeutic benefits once rabies virus (RABV) has entered the CNS, as they cannot cross the blood brain barrier (BBB), a dense cellular network that extends along all capillaries and consists of tight junctions of endothelial cells that prevent the entry of large bacterial pathogens and molecules into the cerebrospinal fluid.",
            "startOffset": 19277,
            "title": "Introduction"
        },
        {
            "endOffset": 21522,
            "parents": [],
            "secId": "s0005",
            "sentence": "Finally, the ability of ScFv/RVG to act as a potential post-exposure tool was assessed in vivo.",
            "startOffset": 21427,
            "title": "Introduction"
        },
        {
            "endOffset": 23465,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Proteins were visualised by Coomasie staining, or electrophoretically transferred to a nitrocellulose membrane for immunoblotting.",
            "startOffset": 23335,
            "title": "SDS-PAGE and western blot"
        },
        {
            "endOffset": 27082,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Treatments with Favipiravir (T-705, a broad-spectrum RNA polymerase inhibitor), and T-705 with ScFv/RVG were also included in the study.",
            "startOffset": 26946,
            "title": "In vivo assessment of ScFV/RVG"
        },
        {
            "endOffset": 39266,
            "parents": [],
            "refoffsets": {
                "b0275": {
                    "endOffset": 39265,
                    "startOffset": 39261
                }
            },
            "secId": "s0075",
            "sentence": "This is likely to be due to different pharmacokinetics, as without Fc, ScFv/RVG would be expected to have a shorter serum half life [55].",
            "startOffset": 39129,
            "title": "Discussion"
        },
        {
            "endOffset": 35354,
            "parents": [],
            "secId": "s0075",
            "sentence": "The lyssavirus neutralisation activity of the ScFv was equivalent to that of the IgG parent antibody.",
            "startOffset": 35253,
            "title": "Discussion"
        },
        {
            "endOffset": 22515,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "10 mg of ScFv (MW = 56 kDa) and the linker (succinimidyl-4-formylbenzamide) were dissolved in PBS.",
            "startOffset": 22417,
            "title": "ScFv and ScFv/RVG production"
        },
        {
            "endOffset": 33892,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "T705 reduced mortality to a similar degree compared with ScFv/RVG (Figs. 6B, 7), and the group treated with the combination of ScFv/RVG conjugate with T-705 reduced mortality to a level similar to HRIG (Fig. 6B, 7).",
            "startOffset": 33677,
            "title": "In vivo assessment of ScFv/RVG"
        },
        {
            "endOffset": 23705,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Nitro-cellulose membranes were blocked (5% non-fat dried milk, 0.1% Tween20 in PBS) before being probed with horseradish peroxidase (HRP) conjugated mouse anti-E-tag antiserum (Abcam, UK) diluted at 1:5000 in 1% non-fat dried milk in PBST.",
            "startOffset": 23466,
            "title": "SDS-PAGE and western blot"
        },
        {
            "endOffset": 25609,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "The binding and competition assays were analyzed in three independent experiments.",
            "startOffset": 25527,
            "title": "nAchR binding and competition assay"
        },
        {
            "endOffset": 38541,
            "parents": [],
            "secId": "s0075",
            "sentence": "However, the results suggest that the virus took longer to reach the CNS than expected.",
            "startOffset": 38454,
            "title": "Discussion"
        },
        {
            "endOffset": 21188,
            "parents": [],
            "secId": "s0005",
            "sentence": "In the current study, the ScFv was expressed also in N. benthamiana but chemically conjugated to synthetic 29 amino acid peptide (ScFv/RVG) for evaluation.",
            "startOffset": 21033,
            "title": "Introduction"
        },
        {
            "endOffset": 23247,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Crude protein extracts from plant leaves were prepared 5 days after agro-infiltration and denatured by boiling in NuPAGE\u00ae LDS Sample Buffer.",
            "startOffset": 23107,
            "title": "SDS-PAGE and western blot"
        },
        {
            "endOffset": 32754,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "There was some detectable ScFv in the bottom chamber at both time points, but as the levels were similar at both time points, we interpret this to represent slight leakage of the monolayer to small proteins.",
            "startOffset": 32547,
            "title": "Passage of ScFv/RVG conjugate across an in vitro model of the blood brain barrier"
        },
        {
            "endOffset": 34305,
            "parents": [],
            "secId": "s0075",
            "sentence": "The blood-brain barrier remains a major bottleneck for drug development, for rabies and many other brain diseases.",
            "startOffset": 34191,
            "title": "Discussion"
        },
        {
            "endOffset": 36025,
            "parents": [],
            "secId": "s0075",
            "sentence": "In this study, our strategy was to express the 62-71-3 ScFv molecule separately in Nicotiana benthamiana and following purification, use chemical conjugation to synthetic RVG peptide.",
            "startOffset": 35842,
            "title": "Discussion"
        },
        {
            "endOffset": 22281,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0150": {
                    "endOffset": 22280,
                    "startOffset": 22276
                }
            },
            "secId": "s0015",
            "sentence": "The resulting recombinant bacterial strains were verified by restriction digest of plasmids, grown overnight at 28 \u00b0C and used to infiltrate leaves of 6\u20138 week-old greenhouse-grown N. benthamiana plants, by vacuum infiltration as described [30].",
            "startOffset": 22036,
            "title": "ScFv and ScFv/RVG production"
        },
        {
            "endOffset": 35706,
            "parents": [],
            "secId": "s0075",
            "sentence": "However, the expression level of this molecule in plants was extremely low, approximately 2 mg/kg fresh leaf weight, which is significantly below the level required for commercial viability.",
            "startOffset": 35516,
            "title": "Discussion"
        },
        {
            "endOffset": 39660,
            "parents": [],
            "secId": "s0075",
            "sentence": "The relative performance of ScFv/RVG and HRIG when treatment is sufficiently delayed for mortality to be high with HRIG treatment remains unknown.",
            "startOffset": 39514,
            "title": "Discussion"
        },
        {
            "endOffset": 40160,
            "parents": [],
            "secId": "s0075",
            "sentence": "In conclusion, the adaptation of ScFv through conjugation to a 29 amino acid RVG peptide has enabled greater bioavailability of the molecule.",
            "startOffset": 40019,
            "title": "Discussion"
        },
        {
            "endOffset": 40765,
            "parents": [],
            "secId": "s0075",
            "sentence": "The development and clinical evaluation of new tools for post exposure control for rabies virus infection in endemic areas is a matter of some urgency.",
            "startOffset": 40614,
            "title": "Discussion"
        },
        {
            "endOffset": 30256,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Higher molecular weight bands (approximately 150 kDa) are likely to represent ScFv aggregates, whilst lower molecular weight bands (30\u201335 kDa) are likely to represent ScFv degradation products.",
            "startOffset": 30063,
            "title": "Characterisation of the 62-71-3 ScFv and the ScFv/RVG conjugate"
        },
        {
            "endOffset": 39513,
            "parents": [],
            "secId": "s0075",
            "sentence": "However, the combination of ScFv/RVG with T-705 appeared to match the protection from HRIG, most likely because the effects of ScFv/FVG and T-705 were additive, but the evidence is not decisive.",
            "startOffset": 39319,
            "title": "Discussion"
        },
        {
            "endOffset": 24980,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "For the entry assay, samples were washed 3 times with permeabilization buffer (1% inactivated fetal calf serum, 0.1% NaN3, and 0.1% Saponin in PBS, pH 7.4) before the cells were incubated with 1:1000 mouse anti-E tag antiserum at 4 \u00b0C, overnight.",
            "startOffset": 24734,
            "title": "nAchR binding and competition assay"
        },
        {
            "endOffset": 19209,
            "parents": [],
            "secId": "s0005",
            "sentence": "Furthermore, in remote areas, travel to medical centres for treatment can delay treatment.",
            "startOffset": 19119,
            "title": "Introduction"
        },
        {
            "endOffset": 18541,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 18540,
                    "startOffset": 18537
                }
            },
            "secId": "s0005",
            "sentence": "Regardless, it is during the phase between virus replication in the non-neuronal periphery and movement into the peripheral nervous system that post exposure immunoprophylaxis is hypothesised to be most effective [4].",
            "startOffset": 18324,
            "title": "Introduction"
        },
        {
            "endOffset": 23334,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Proteins were separated on 4\u201312% gradient polyacrylamide gels (Life Technologies, UK).",
            "startOffset": 23248,
            "title": "SDS-PAGE and western blot"
        },
        {
            "endOffset": 31070,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "A greater proportion of ScFv/RVG bound to the 293 cells as evidenced by the shift to the right of the dotted line compared to ScFv (solid line) (Fig. 3A).",
            "startOffset": 30916,
            "title": "Binding to nAchR and cell entry"
        },
        {
            "endOffset": 32369,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "No evidence for the ability of full length 62-71-3 mAb to cross the cell monolayer was found.",
            "startOffset": 32276,
            "title": "Passage of ScFv/RVG conjugate across an in vitro model of the blood brain barrier"
        },
        {
            "endOffset": 22803,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "10 mg of the peptide (MW = 3 kDa) was dissolved in water and adjusted to pH7 with PBS.",
            "startOffset": 22717,
            "title": "ScFv and ScFv/RVG production"
        },
        {
            "endOffset": 38713,
            "parents": [],
            "secId": "s0075",
            "sentence": "HRIG was protective when delivered at all time points, even though it is well established that HRIG does not provide protection once rabies virus infection enters the CNS.",
            "startOffset": 38542,
            "title": "Discussion"
        },
        {
            "endOffset": 23945,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0155": {
                    "endOffset": 23944,
                    "startOffset": 23940
                }
            },
            "secId": "s0025",
            "sentence": "Human embryonic kidney 293 cells expressing human \u03b17-nicotinic acetylcholine receptor (HEKnAchR7) were reported previously [31].",
            "startOffset": 23817,
            "title": "Cells and viruses"
        },
        {
            "endOffset": 27552,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Each group of 12 mice was randomly split across two boxes of 6 mice each, to take account of interactions among mice sharing boxes and any other differences between boxes.",
            "startOffset": 27381,
            "title": "In vivo assessment of ScFV/RVG"
        },
        {
            "endOffset": 26945,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Intra-peritoneal administration (IP) of ScFv/RVG was compared to treatment with human rabies immunoglobulin (HRIG) as both a pre- and post-exposure treatment.",
            "startOffset": 26787,
            "title": "In vivo assessment of ScFV/RVG"
        },
        {
            "endOffset": 22416,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0140": {
                    "endOffset": 22415,
                    "startOffset": 22411
                }
            },
            "secId": "s0015",
            "sentence": "The recombinant plant expressed antibodies were extracted in 3 volumes of PBS (pH7.4) and purified by Ni-affinity chromatography [28].",
            "startOffset": 22282,
            "title": "ScFv and ScFv/RVG production"
        },
        {
            "endOffset": 35122,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 35084,
                    "startOffset": 35080
                },
                "b0110": {
                    "endOffset": 35105,
                    "startOffset": 35098
                },
                "b0255": {
                    "endOffset": 35105,
                    "startOffset": 35098
                }
            },
            "secId": "s0075",
            "sentence": "Several studies have demonstrated that RVG peptide can deliver siRNA [21] and proteins [22,51] through the BBB.",
            "startOffset": 35011,
            "title": "Discussion"
        },
        {
            "endOffset": 36397,
            "parents": [],
            "secId": "s0075",
            "sentence": "Chemical conjugation of RVG peptide to ScFv is also potentially advantageous because multiple peptides could be attached to a single ScFv molecule, thereby increasing affinity for the nAchR.",
            "startOffset": 36207,
            "title": "Discussion"
        },
        {
            "endOffset": 33438,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Unexpectedly, even 4 days after viral challenge, HRIG was almost totally protective, and there was no evidence of any effect from the timing of treatments.",
            "startOffset": 33283,
            "title": "In vivo assessment of ScFv/RVG"
        },
        {
            "endOffset": 40322,
            "parents": [],
            "secId": "s0075",
            "sentence": "In particular, the approach adopted in this study overcomes the problem of low yield, and the scalable production of rabies ScFv molecule in plants is promising.",
            "startOffset": 40161,
            "title": "Discussion"
        },
        {
            "endOffset": 31411,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "The specificity of binding between ScFv/RVG and HEK 293 cells via nAchR was tested by a competitive assay using irradiated rabies virus and \u03b1-bungarotoxin.",
            "startOffset": 31256,
            "title": "Binding to nAchR and cell entry"
        },
        {
            "endOffset": 31513,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "The HEK 293 cell line was pre-incubated with each inhibitor, before incubation with ScFv or ScFv/RVG.",
            "startOffset": 31412,
            "title": "Binding to nAchR and cell entry"
        },
        {
            "endOffset": 38995,
            "parents": [],
            "secId": "s0075",
            "sentence": "With no significant effect from the timing of treatments, ScFv/RVG halved mortality relative to the control treatment, but did not match the 90% protection observed for HRIG.",
            "startOffset": 38821,
            "title": "Discussion"
        },
        {
            "endOffset": 29743,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "The purified ScFv and the ScFv/RVG conjugate were assessed by SDS-PAGE gel followed by Coomassie staining (Fig. 1A) or by immunoblotting with horseradish peroxidase conjugated mouse anti-E tag antiserum (Fig. 1B).",
            "startOffset": 29530,
            "title": "Characterisation of the 62-71-3 ScFv and the ScFv/RVG conjugate"
        },
        {
            "endOffset": 40613,
            "parents": [],
            "secId": "s0075",
            "sentence": "This leads to the possibility for rapid large scale production of the conjugated molecule and relatively quick translation to clinical trial.",
            "startOffset": 40472,
            "title": "Discussion"
        },
        {
            "endOffset": 28200,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Mice were weighed daily during the 10 day treatment period to determine both weight loss due to infection and assign any possible adverse effect of treatment with ScFv, T705 or HRIG.",
            "startOffset": 28018,
            "title": "In vivo assessment of ScFV/RVG"
        },
        {
            "endOffset": 34180,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "However, although the best model of the experimental observations was that the effects of T705 and ScFv/RVG were additive, the difference between T705 alone and the combination of T705 with ScFv/RVG conjugate did not reach the threshold for statistical significance at P < 0.05 (Fig. 7).",
            "startOffset": 33893,
            "title": "In vivo assessment of ScFv/RVG"
        },
        {
            "endOffset": 32094,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0175": {
                    "endOffset": 32093,
                    "startOffset": 32089
                }
            },
            "secId": "s0065",
            "sentence": "An in vitro BBB transport experiment was conducted on an hCMEC/D3 cell monolayer as described previously [35].",
            "startOffset": 31984,
            "title": "Passage of ScFv/RVG conjugate across an in vitro model of the blood brain barrier"
        },
        {
            "endOffset": 22716,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The RVG peptide was synthesized by Pepscan (Lelystad, The Netherlands).",
            "startOffset": 22645,
            "title": "ScFv and ScFv/RVG production"
        },
        {
            "endOffset": 21032,
            "parents": [],
            "secId": "s0005",
            "sentence": "However, ScFv-RVG fusion was poorly expressed, so although promising, this strategy was not deemed feasible for further development.",
            "startOffset": 20900,
            "title": "Introduction"
        },
        {
            "endOffset": 27380,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Mice were tagged and numbered before using a random number generator to distribute mice into groups.",
            "startOffset": 27280,
            "title": "In vivo assessment of ScFV/RVG"
        },
        {
            "endOffset": 17465,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 17464,
                    "startOffset": 17461
                }
            },
            "secId": "s0005",
            "sentence": "RABV is a non-segmented negative strand RNA virus in the order Mononegavirales, family Rhabdoviridae, genus lyssavirus [1].",
            "startOffset": 17342,
            "title": "Introduction"
        },
        {
            "endOffset": 40471,
            "parents": [],
            "secId": "s0075",
            "sentence": "RVG peptide synthesis and the conjugation process are readily available commercially and available under Good Manufacturing Practice when necessary.",
            "startOffset": 40323,
            "title": "Discussion"
        },
        {
            "endOffset": 22644,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The linker solution was added to the ScFv solution under stirring, and the solution was agitated for 30 min in room temperature.",
            "startOffset": 22516,
            "title": "ScFv and ScFv/RVG production"
        },
        {
            "endOffset": 26485,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "10 \u00b5g of antibody preparation was added to the top chamber and the cells were incubated (37 \u00b0C; 5% CO2) and samples were taken after 2 h and 18 h to assess the media in the bottom chamber for the presence of antibody by virus neutralisation.",
            "startOffset": 26244,
            "title": "In vitro BBB transwell assay"
        },
        {
            "endOffset": 38820,
            "parents": [],
            "secId": "s0075",
            "sentence": "So unfortunately, no conclusions can be drawn regarding potential ScFv mediated protection within the CNS.",
            "startOffset": 38714,
            "title": "Discussion"
        },
        {
            "endOffset": 26708,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "All in vivo work was undertaken in BSL3/SAPO4 containment at the Animal and Plant Health Agency (APHA), following independent ethical review under strict Home Office guidelines (PPL70/7394).",
            "startOffset": 26518,
            "title": "In vivo assessment of ScFV/RVG"
        },
        {
            "endOffset": 35515,
            "parents": [],
            "refoffsets": {
                "b0140": {
                    "endOffset": 35514,
                    "startOffset": 35510
                }
            },
            "secId": "s0075",
            "sentence": "In a preliminary study, an ScFv-RVG fusion protein was engineered, and we were able to demonstrate some of the functional characteristics of this molecule [28].",
            "startOffset": 35355,
            "title": "Discussion"
        },
        {
            "endOffset": 19276,
            "parents": [],
            "refoffsets": {
                "b0050": {
                    "endOffset": 19275,
                    "startOffset": 19268
                },
                "b0055": {
                    "endOffset": 19275,
                    "startOffset": 19268
                },
                "b0060": {
                    "endOffset": 19275,
                    "startOffset": 19268
                }
            },
            "secId": "s0005",
            "sentence": "If clinical disease develops, PEP is entirely ineffective [10\u201312].",
            "startOffset": 19210,
            "title": "Introduction"
        },
        {
            "endOffset": 27279,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Mice (n = 12/group) received ScFv/RVG (40 IU/kg), HRIG (40 IU/kg), T-705 (300 mg/kg) or ScFv/RVG (40 IU/kg) + T-705 (300 mg/kg) or were controls receiving PBS following the same treatment schedule.",
            "startOffset": 27082,
            "title": "In vivo assessment of ScFV/RVG"
        },
        {
            "endOffset": 32467,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0140": {
                    "endOffset": 32418,
                    "startOffset": 32411
                },
                "b0185": {
                    "endOffset": 32418,
                    "startOffset": 32411
                }
            },
            "secId": "s0065",
            "sentence": "This is consistent with previous reports [28,37] and demonstrates the integrity of the monolayer.",
            "startOffset": 32370,
            "title": "Passage of ScFv/RVG conjugate across an in vitro model of the blood brain barrier"
        },
        {
            "endOffset": 17638,
            "parents": [],
            "secId": "s0005",
            "sentence": "Rhabdoviruses are enveloped with a typical bullet- or rod-shaped morphology and characterized by an extremely broad host spectrum ranging from plants to insects to mammals.",
            "startOffset": 17466,
            "title": "Introduction"
        },
        {
            "endOffset": 36971,
            "parents": [],
            "secId": "s0075",
            "sentence": "The ScFv/RVG conjugate did mediate binding and entry into cells overexpressing nAchR and a neuron-like cell line (neuroscreen cells) and the role of nAchR in this interaction was demonstrated by the ability of both rabies virus and alpha-bungarotoxin to competitively inhibit ScFv.",
            "startOffset": 36690,
            "title": "Discussion"
        },
        {
            "endOffset": 31256,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "After a longer incubation (30 min) a greater amount of ScFv/RVG was associated with the 293 cells compared to ScFv (Fig. 3B), and this represents ScFv that has entered the target cells.",
            "startOffset": 31071,
            "title": "Binding to nAchR and cell entry"
        },
        {
            "endOffset": 21426,
            "parents": [],
            "secId": "s0005",
            "sentence": "In comparison to ScFv alone, ScFv/RVG demonstrated enhanced ability to cross an in vivo 3D cell culture BBB model via a mechanism that involves the N-acetylcholine receptor.",
            "startOffset": 21253,
            "title": "Introduction"
        },
        {
            "endOffset": 27605,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Groups of mice were treated for 10 consecutive days.",
            "startOffset": 27553,
            "title": "In vivo assessment of ScFV/RVG"
        },
        {
            "endOffset": 30754,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "The starting concentrations for all three antibodies was 0.5 mg/ml and the results suggest that the neutralizing activity of ScFv and ScFv/RVG conjugate was not significantly different to that of 62-71-3 mAb (Fig. 2).",
            "startOffset": 30537,
            "title": "Neutralization of rabies virus"
        },
        {
            "endOffset": 36534,
            "parents": [],
            "secId": "s0075",
            "sentence": "Indeed, as shown in the SDS-PAGE and western blot of the ScFv/RVG conjugate, the product band indicates molecules with a range of sizes.",
            "startOffset": 36398,
            "title": "Discussion"
        },
        {
            "endOffset": 25137,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "The cells were then washed as before, before incubation with a goat anti-mouse IgG antiserum conjugated with cy5 (Jackson laboratory, USA) at 37 \u00b0C for 1 h.",
            "startOffset": 24981,
            "title": "nAchR binding and competition assay"
        },
        {
            "endOffset": 17341,
            "parents": [],
            "secId": "s0005",
            "sentence": "Rabies is a neglected disease caused by Rabies virus (RABV) that affects people in many countries, mostly in Asia and Africa.",
            "startOffset": 17216,
            "title": "Introduction"
        },
        {
            "endOffset": 33134,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "The effectiveness of the ScFv/RVG conjugate against rabies viral challenge was assessed in vivo.",
            "startOffset": 33038,
            "title": "In vivo assessment of ScFv/RVG"
        },
        {
            "endOffset": 27909,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0180": {
                    "endOffset": 27908,
                    "startOffset": 27904
                }
            },
            "secId": "s0040",
            "sentence": "Virus used for inoculation was a bat rabies strain originally isolated from a human fatality following infection from an insectivorous bat [36].",
            "startOffset": 27765,
            "title": "In vivo assessment of ScFV/RVG"
        },
        {
            "endOffset": 35252,
            "parents": [],
            "refoffsets": {
                "b0135": {
                    "endOffset": 35251,
                    "startOffset": 35247
                }
            },
            "secId": "s0075",
            "sentence": "Our previous work demonstrated expression of a ScFv version of the rabies neutralising monoclonal antibody 62-71-3 in planta [27].",
            "startOffset": 35122,
            "title": "Discussion"
        },
        {
            "endOffset": 37208,
            "parents": [],
            "secId": "s0075",
            "sentence": "An in vitro model was utilised to investigate the potential transport of different antibody based molecules across the blood brain barrier.",
            "startOffset": 37069,
            "title": "Discussion"
        },
        {
            "endOffset": 31784,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "However, for ScFv/RVG there was a shift, with less ScFv/RVG detected within the cells in the presence of both inhibitors (Fig. 4B and D, respectively).",
            "startOffset": 31633,
            "title": "Binding to nAchR and cell entry"
        },
        {
            "endOffset": 28017,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Mice were challenged with 50 \u00b5l RABV at \u223c105.8 TCID50/ml by intramuscular injection into the left hind leg.",
            "startOffset": 27910,
            "title": "In vivo assessment of ScFV/RVG"
        },
        {
            "endOffset": 31900,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "The assays were repeated using Neuroscreen-1 cells, a model neuronal cell line, with identical results (Fig. 4E\u2013H).",
            "startOffset": 31785,
            "title": "Binding to nAchR and cell entry"
        },
        {
            "endOffset": 39318,
            "parents": [],
            "secId": "s0075",
            "sentence": "Favipiravir (T705) performed similarly to ScFv/RVG.",
            "startOffset": 39267,
            "title": "Discussion"
        },
        {
            "endOffset": 22947,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "After the linker/ScFv solution was dialyzed in PBS for 15 min 4 times, it was added to the peptide solution under stirring at room temperature.",
            "startOffset": 22804,
            "title": "ScFv and ScFv/RVG production"
        },
        {
            "endOffset": 30002,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "ScFv/RVG migrated slightly slower than ScFv as expected and the slight smearing of this band is consistent with variable levels of RVG peptide conjugation.",
            "startOffset": 29847,
            "title": "Characterisation of the 62-71-3 ScFv and the ScFv/RVG conjugate"
        },
        {
            "endOffset": 19118,
            "parents": [],
            "secId": "s0005",
            "sentence": "However, in endemic regions, knowledge of the most effective actions to take following an exposure event is often limited, as is the availability of PEP.",
            "startOffset": 18965,
            "title": "Introduction"
        },
        {
            "endOffset": 26786,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Molecules were administered to groups of mice by intraperitoneal inoculation.",
            "startOffset": 26709,
            "title": "In vivo assessment of ScFV/RVG"
        },
        {
            "endOffset": 37069,
            "parents": [],
            "refoffsets": {
                "b0265": {
                    "endOffset": 37068,
                    "startOffset": 37064
                }
            },
            "secId": "s0075",
            "sentence": "Alpha-bungarotoxin is a neurotoxin that binds nAchR at the same site as rabies glycoprotein [53].",
            "startOffset": 36972,
            "title": "Discussion"
        },
        {
            "endOffset": 26079,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Cells were seeded on the apical side of a Cultrex\u00ae Rat Collagen I (150 \u03bcg/ml; R&D Systems, USA) coated 0.9 cm2 polyethylene terephthalate filter insert with 3.0 \u03bcm porosity (BD Falcon, UK).",
            "startOffset": 25890,
            "title": "In vitro BBB transwell assay"
        },
        {
            "endOffset": 30323,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "The identity of the bands was supported by western blot (Fig. 1B).",
            "startOffset": 30257,
            "title": "Characterisation of the 62-71-3 ScFv and the ScFv/RVG conjugate"
        },
        {
            "endOffset": 18844,
            "parents": [],
            "refoffsets": {
                "b0025": {
                    "endOffset": 18843,
                    "startOffset": 18840
                }
            },
            "secId": "s0005",
            "sentence": "Current options for rabies post exposure treatment include immunoprohylaxis with human or equine rabies immunoglobulin (H/ERIG) at the site of the infection and vaccination at a site distant from the exposure to ensure that the application of RIG does not interfere with the humoral immune response [5].",
            "startOffset": 18541,
            "title": "Introduction"
        },
        {
            "endOffset": 24479,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "After 24 h, cells were placed on ice and incubated with ScFv or ScFv/RVG for 5 min (binding assay) or 30 min (entry assay).",
            "startOffset": 24356,
            "title": "nAchR binding and competition assay"
        },
        {
            "endOffset": 25291,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "After further washing, the cells were resuspended in staining buffer and analysed by flow cytometry, using FACS CellQuest software (BD Biosciences, USA).",
            "startOffset": 25138,
            "title": "nAchR binding and competition assay"
        },
        {
            "endOffset": 20116,
            "parents": [],
            "refoffsets": {
                "b0080": {
                    "endOffset": 20053,
                    "startOffset": 20049
                },
                "b0085": {
                    "endOffset": 20115,
                    "startOffset": 20108
                },
                "b0090": {
                    "endOffset": 20115,
                    "startOffset": 20108
                },
                "b0095": {
                    "endOffset": 20115,
                    "startOffset": 20108
                },
                "b0100": {
                    "endOffset": 20115,
                    "startOffset": 20108
                }
            },
            "secId": "s0005",
            "sentence": "Prior to the establishment of a productive infection of the CNS, RABV utilises nAchRs [16] to enter both muscle and nerve cells in the periphery [17\u201320].",
            "startOffset": 19963,
            "title": "Introduction"
        },
        {
            "endOffset": 30536,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "The parent monoclonal antibody (62-71-3) and two versions of ScFv were tested to determine their capability to neutralize rabies virus (ERA strain) using a plaque-inhibition assay.",
            "startOffset": 30356,
            "title": "Neutralization of rabies virus"
        },
        {
            "endOffset": 36206,
            "parents": [],
            "secId": "s0075",
            "sentence": "The ScFv was expressed at 35\u201350 mg/kg fresh leaf weight which has important advantages in terms of downstream processing and purification, and consequently on commercial viability.",
            "startOffset": 36026,
            "title": "Discussion"
        },
        {
            "endOffset": 21892,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0135": {
                    "endOffset": 21783,
                    "startOffset": 21779
                },
                "b0145": {
                    "endOffset": 21891,
                    "startOffset": 21887
                }
            },
            "secId": "s0015",
            "sentence": "The pEAQ-62-71-3 IgG [27] and the pEAQ-ScFv vectors used for expression of recombinant antibodies have been described previously [29].",
            "startOffset": 21758,
            "title": "ScFv and ScFv/RVG production"
        },
        {
            "endOffset": 34478,
            "parents": [],
            "refoffsets": {
                "b0190": {
                    "endOffset": 34406,
                    "startOffset": 34402
                },
                "b0195": {
                    "endOffset": 34436,
                    "startOffset": 34432
                },
                "b0200": {
                    "endOffset": 34451,
                    "startOffset": 34447
                },
                "b0205": {
                    "endOffset": 34472,
                    "startOffset": 34468
                }
            },
            "secId": "s0075",
            "sentence": "Several strategies have been developed, including the use of nanotechnology employing liposomes [38], polymeric nanoparticles [39], micelles [40], gold particles [41], etc.",
            "startOffset": 34306,
            "title": "Discussion"
        },
        {
            "endOffset": 24355,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "HEK 293 cells or Neuroscreen-1 (Thermo-Fisher, UK) cells were seeded on 6-well plates.",
            "startOffset": 24269,
            "title": "nAchR binding and competition assay"
        },
        {
            "endOffset": 36689,
            "parents": [],
            "secId": "s0075",
            "sentence": "Importantly, RVG conjugation did not affect rabies neutralisation activity, and there was no discernible difference between unconjugated ScFv and ScFv/RVG.",
            "startOffset": 36534,
            "title": "Discussion"
        },
        {
            "endOffset": 38454,
            "parents": [],
            "refoffsets": {
                "b0270": {
                    "endOffset": 38453,
                    "startOffset": 38449
                }
            },
            "secId": "s0075",
            "sentence": "The 4 day post inoculation treatment schedule was chosen because it was expected that an infection of the central nervous system would have established, so it should be possible to demonstrate protective efficacy from ScFv/RVG due to greater accessibility to the brain [54].",
            "startOffset": 38180,
            "title": "Discussion"
        },
        {
            "endOffset": 34620,
            "parents": [],
            "secId": "s0075",
            "sentence": "Another strategy is the use of antibodies to target receptors on the surface of endothelial cells allowing transport of drugs into the brain.",
            "startOffset": 34479,
            "title": "Discussion"
        },
        {
            "endOffset": 28265,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Animals were monitored for 54 days and any deaths were recorded.",
            "startOffset": 28201,
            "title": "In vivo assessment of ScFV/RVG"
        },
        {
            "endOffset": 33005,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "In contrast, a greater amount of ScFv/RVG passed through the hCMEC/D3 cells, and the concentration of ScFv/RVG as measured by virus neutralising activity of the media in the bottom well increased approximately 100-fold after 18hr incubation (Fig. 5).",
            "startOffset": 32755,
            "title": "Passage of ScFv/RVG conjugate across an in vitro model of the blood brain barrier"
        }
    ],
    "docId": "S0264410X18302445",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "Waranyoo",
                "initial": "W.",
                "last": "Phoolcharoen"
            },
            {
                "email": null,
                "first": "Ashley C.",
                "initial": "A.C.",
                "last": "Banyard"
            },
            {
                "email": null,
                "first": "Christophe",
                "initial": "C.",
                "last": "Prehaud"
            },
            {
                "email": null,
                "first": "D.",
                "initial": "D.",
                "last": "Selden"
            },
            {
                "email": null,
                "first": "Guanghui",
                "initial": "G.",
                "last": "Wu"
            },
            {
                "email": null,
                "first": "Colin P.D.",
                "initial": "C.P.D.",
                "last": "Birch"
            },
            {
                "email": null,
                "first": "T. H.",
                "initial": "T.H.",
                "last": "Szeto"
            },
            {
                "email": null,
                "first": "Monique",
                "initial": "M.",
                "last": "Lafon"
            },
            {
                "email": null,
                "first": "Anthony R.",
                "initial": "A.R.",
                "last": "Fooks"
            },
            {
                "email": "jma@sgul.ac.uk",
                "first": "Julian K.C.",
                "initial": "J.K.C.",
                "last": "Ma"
            }
        ],
        "doi": "10.1016/j.vaccine.2018.02.057",
        "firstpage": "4673",
        "issn": "0264410X",
        "keywords": [
            "Blood brain barrier (BBB)",
            "Clinical disease",
            "Immunoglobulin",
            "N-acetylcholine receptor",
            "Nicotiana benthamiana",
            "Rabies virus",
            "Single-chain antibody (ScFv)"
        ],
        "lastpage": "4680",
        "openaccess": "Full",
        "pub_year": 2019,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "In vitro and in vivo evaluation of a single chain antibody fragment generated in planta with potent rabies neutralisation activity"
    }
}